Infection Prevention
FDA approves seasonal flu vaccine made using novel technology
On Jan. 16, 2012, the U.S. Food and Drug Administration (FDA) approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus)…
FDA approves drug to treat multi-drug resistant TB
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug…
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral…
Study: Donor feces more effective than vancomycin in treatment of recurrent C. difficile
A study in The New England Journal of Medicine found that infusing a solution of donor feces through a nasoduodenal tube was “significantly more…
Study: Disinfecting caps reduce CLABSI rates
Using a disinfection cap (with isopropyl alcohol) on central line catheters significantly reduced central-line associated bloodstream infection (CLABSI) rates, according to a study in…
Helping patients survive sepsis
In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.
Study: Health care organizations reduce SSIs by nearly half with Joint Commission project
A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons reduced surgical…
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…
Study: Urinary catheterization high risk for UTI
A review article in December 2012’s Journal of Hospital Infection found that highest population-attributable risk percentage for urinary tract infection (UTI) was associated with…
A probable meningitis case puts the ED on alert
The care team works quickly to identify the patient’s meningitis type.
FDA approves seasonal flu vaccine made using novel technology
On Jan. 16, 2012, the U.S. Food and Drug Administration (FDA) approved Flublok, the first trivalent influenza vaccine made using an insect…
FDA approves drug to treat multi-drug resistant TB
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Sirturo (bedaquiline) as part of combination therapy to treat adults…
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients…
Study: Donor feces more effective than vancomycin in treatment of recurrent C. difficile
A study in The New England Journal of Medicine found that infusing a solution of donor feces through a nasoduodenal tube was…
Study: Disinfecting caps reduce CLABSI rates
Using a disinfection cap (with isopropyl alcohol) on central line catheters significantly reduced central-line associated bloodstream infection (CLABSI) rates, according to a…
Helping patients survive sepsis
In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.
Study: Health care organizations reduce SSIs by nearly half with Joint Commission project
A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons…
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid…
Study: Urinary catheterization high risk for UTI
A review article in December 2012’s Journal of Hospital Infection found that highest population-attributable risk percentage for urinary tract infection (UTI) was…
A probable meningitis case puts the ED on alert
The care team works quickly to identify the patient’s meningitis type.
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.